US imports 40% of generics from India on trust, says Ambassador Sergio Gor
Synopsis
Key Takeaways
US Ambassador to India Sergio Gor on Friday said the United States sources nearly 40 per cent of its generic medicines from India, citing trust in the country's pharmaceutical capabilities as the primary reason. Gor made the remarks at the Advancing Partnership in Research and Innovation event held at the Indian Institute of Technology (IIT), New Delhi.
Why the US Relies on Indian Generics
'On pharmaceuticals, we import close to 40 per cent of our generics from India. There is a reason the United States does that: it is because we trust India. These are critical life-saving ingredients that are needed in the United States,' Gor said. The remark underscores India's entrenched position in global pharmaceutical supply chains — a role that has only grown since the COVID-19 pandemic exposed the risks of concentrated drug manufacturing in a single region.
Bilateral Trade: From $20 Billion to $220 Billion
Gor described the India-US relationship as 'one of the defining partnerships of the 21st century,' pointing to a dramatic expansion in bilateral trade over two decades. 'In just over two decades, bilateral trade has grown from $20 billion to over $220 billion in goods and services. That's not just volume; it reflects deeper, broader engagement and stronger economic integration,' he said. This tenfold increase places India among America's most consequential trading partners, a shift that has accelerated since India's economic liberalisation deepened in the 2000s.
Interim Trade Deal 'In Final Stages'
The Ambassador also expressed confidence that a proposed interim trade agreement between the two countries is close to completion. 'Our current interim trade agreement is on the table for us to finalise that will unlock prosperity for both of our countries. We fully expect that the trade deal will be signed over the next few weeks and months,' Gor said. Notably, the statement comes at a time when India and the US are navigating tariff tensions, making the prospect of a bilateral deal particularly consequential for exporters on both sides.
US Tech Giants Bet Big on India
Gor highlighted a wave of large-scale American corporate investments flowing into India. Amazon plans to invest $35 billion in India by 2030 to support AI-driven digitisation, exports, and job creation. Microsoft has announced an investment of $17.5 billion, including the expansion of hyperscale cloud infrastructure. Google, meanwhile, recently began work on a subsea cable landing terminal project valued at approximately $15 billion. 'These are incredible things that we have seen just from a handful of companies,' Gor said, adding that investors who approach the US Embassy about India's investment climate consistently receive a clear answer: 'Our answer to them is yes.'
What This Signals for India-US Ties
The remarks, delivered at one of India's premier technology institutions, signal a deliberate effort by Washington to reinforce the strategic and economic depth of the bilateral relationship. From pharmaceuticals to cloud infrastructure, the US is publicly anchoring its supply-chain and technology bets to India. The next concrete test of that intent will be whether the interim trade deal clears in the timeline Gor outlined.